Participants 140 201 6
patients with progressive castrate metastatic prostate cancer
Participants 348 429 5
chemotherapy-naive patients with progressive castrate metastatic prostate cancer.
Participants 633 811 7
Between December 2001 and October 2003, 92 patients were enrolled and randomly assigned to treatment with ixabepilone alone (45 patients) or in combination with EMP (47 patients)
